MedPath

Evaluation of safety and efficacy of autologous stentless mitral valve replacement: pilot study

Not Applicable
Conditions
mitral valve stenosis, mitral valve stenosis and regurgitation
Registration Number
JPRN-UMIN000026020
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1. Malignancy 2. Hemodialysis 3. Included other clinical study 4. Myocardial infarction within 6 months 5. Strole within 6 months 6. Coronary intervention within 1 months 7. Indication for other cardiac diseases (tricuspid, atrial fibrillation excluded) 8. sever left ventricular dysfunction 9. Conventional treatment is expected to be the best.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath